Emergent BioSolutions (EBS) Revenue (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Revenue of $156.1 million for Q1 2026, down 29.75% year-over-year from $222.2 million in Q1 2025, and up 4.98% quarter-over-quarter from $148.7 million in Q4 2025.
Emergent BioSolutions (EBS) Revenue (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Revenue history runs 16 years deep, the most recent figure standing at $156.1 million for Q1 2026.
- In Q1 2026, Revenue fell 29.75% year-over-year to $156.1 million; the TTM figure through Mar 2026 stood at $676.8 million (down 11.03% YoY), while the FY2025 annual figure was $742.9 million, down 28.81% from the prior year.
- Revenue for Q1 2026 stood at $156.1 million, up from $148.7 million in the prior quarter.
- The five-year high for Revenue was $337.9 million in Q2 2023, with the low at $50.0 million in Q2 2024.
- The 5-year median for Revenue is $239.9 million (2022), against an average of $229.7 million.
- The sharpest annual moves came in 2024 and 2025: Revenue plunged 85.2% in 2024, then soared 181.8% in 2025.
- Emergent BioSolutions' Revenue stood at $330.2 million in 2022, then retreated by 16.23% to $276.6 million in 2023, then decreased by 29.61% to $194.7 million in 2024, then fell by 23.63% to $148.7 million in 2025, then grew by 4.98% to $156.1 million in 2026.
- Business Quant data shows EBS's Revenue at $156.1 million in Q1 2026, $148.7 million in Q4 2025, and $231.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 245.00 Mn | 104.10 Mn | 137.20 Mn | 234.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 234.30 Mn |
| Mar 31, 2026 | 156.10 Mn |
| Dec 31, 2025 | 148.70 Mn |
| Sep 30, 2025 | 231.10 Mn |
| Jun 30, 2025 | 140.90 Mn |
| Mar 31, 2025 | 222.20 Mn |
| Dec 31, 2024 | 194.70 Mn |
| Sep 30, 2024 | 293.80 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Mar 31, 2024 | 300.40 Mn |
| Dec 31, 2023 | 276.60 Mn |
| Sep 30, 2023 | 270.50 Mn |
| Jun 30, 2023 | 337.90 Mn |
| Mar 31, 2023 | 164.30 Mn |
| Dec 31, 2022 | 330.20 Mn |
| Sep 30, 2022 | 239.90 Mn |
| Jun 30, 2022 | 242.60 Mn |
| Mar 31, 2022 | 304.80 Mn |
| Dec 31, 2021 | 732.90 Mn |
| Sep 30, 2021 | 286.30 Mn |